Drug intelligence / Profile preview

campylobacter phage

Development stage
Unknown
Lead developer
Intralytix
Modality
Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Topical, Oral
01

Overview

Campylobacter phages are a type of bacteriophage (viruses that infect bacteria) that specifically target and lyse bacteria belonging to the *Campylobacter* genus. The primary targets are *Campylobacter jejuni* and *Campylobacter coli*, which are leading causes of foodborne gastroenteritis in humans. [4, 5] This targeted bactericidal mechanism positions them as a potential alternative to conventional antibiotics, particularly in light of growing antimicrobial resistance. [5, 8] The therapeutic action involves the phage attaching to the surface of a *Campylobacter* bacterium, injecting its genetic material, and using the bacterium's cellular machinery to replicate. This process culminates in the lysis (bursting) of the bacterial cell, which releases a new generation of phages that can infect and destroy other nearby target bacteria. [21] While research into human therapeutics is ongoing, the most advanced application is in food safety. For instance, Intralytix has developed CampyShield™, a cocktail of several Campylobacter phages, which is approved by the FDA as a processing aid to reduce contamination on raw poultry and meat products. [1, 2]

Brand names
CampyShield
02

Targets

Campylobacter jejuni flagellumLOS (Lipooligosaccharide)C. jejuni CPS (Campylobacter jejuni capsular polysaccharide)

Beyond the preview

Go deeper on campylobacter phage.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on campylobacter phage.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call